Latest News about JNJ
Recent news which mentions JNJ
This Super-Safe High-Yield Stock Just Extended Its Dividend Growth Streak to 63 Years in a Row
April 17, 2025
From Motley Fool
From Benzinga
Johnson & Johnson's Q1 Results, FY Guidance Highlight The 'Power Of The Pharma Portfolio'
April 16, 2025
Tickers
JNJ
From Benzinga
From Benzinga
US Stock Futures Waver After Two-Day Rally: Trump's Tariff Moves Could End A 3-Year 'Rolling Recession,' Says Expert
April 15, 2025
From Benzinga
From Benzinga
Earnings Scheduled For April 15, 2025
April 15, 2025
From Benzinga
Johnson & Johnson Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
April 15, 2025
From Benzinga
US Stock Futures Slip As Investors Brace Themselves For Netflix, AmEx Earnings This Week — Nikkei Up On Strong Sentiment
April 14, 2025
From Benzinga
34-Year-Old Making $3,400 a Month in Dividends Shares His Top 7 Stocks — 'Be Lucky and Save Relentlessly'
April 14, 2025
From Benzinga
Novartis Commits $23 Billion To Expand US Manufacturing Over Five Years, Despite Tariffs Uncertainties
April 11, 2025
From Benzinga
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
April 11, 2025
From Benzinga
2 Top Dividend Stocks to Buy Right Now
April 11, 2025
From Motley Fool
From Benzinga
From Benzinga
If Your Portfolio Is Down on the Tariff News, Check Out This Little-Known High-Yield Dividend Stock
April 10, 2025
From Motley Fool
Stock Market Sell-Off Shopping Spree: 3 Top Dividend Stocks I Just Bought to Boost My Passive Income
April 10, 2025
From Motley Fool
The Dow Crashed 4,260 Points in 3 Days: Here Are 3 Dow Stocks That Make for No-Brainer Buys Right Now
April 10, 2025
From Motley Fool
This Johnson & Johnson Analyst Turns Bullish On Shifting Focus From Stelara Concerns To Innovative Medicine
April 09, 2025
Tickers
JNJ
From Benzinga
From Benzinga
From Benzinga
Cell Therapy Maker Legend Biotech Is An 'Attractive Opportunity' Due To No Material Tariff Exposure: Analyst
April 08, 2025
From Benzinga
From Benzinga
Johnson & Johnson's New 'Compelling Data' Shows Sustained Symptom Improvement In Muscular Disease Patients
April 08, 2025
From Benzinga
Why Health Care Select Sector SPDR Fund (XLV) Is Moving
April 07, 2025
From Benzinga
All the Stocks Warren Buffett Bought in the Last 2 Recessions: Are They Smart Picks Now?
April 06, 2025
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.